Collect. Czech. Chem. Commun.
2011, 76, 553-566
https://doi.org/10.1135/cccc2011027
Published online 2011-04-29 13:18:47
Investigations on the polymorphism and pseudopolymorphism of clobetasone butyrate
Christian Näther* and Inke Jeß
Institut für Anorganische Chemie der Christian-Albrechts-Universität zu Kiel, Max.-Eyth.-Str. 2, 24118 Kiel, Germany
References
1. Bernstein J. L: Polymorphism in Molecular Crystals. Clarendon Press, Oxford 2002.
2. Brittain H. G.: Polymorphism in Pharmaceutical Solids, Vol. 23. Marcel Dekker, New York 1999.
3. Hilfiker R.: Polymorphism. Wiley-VCH, Weinheim 2006.
4. Am. Pharm. Rev. 2000, 3, 67.
H. G.:
5a. Angew. Chem. 1999, 111, 3646.
< J., Davey R., Henck O.: https://doi.org/10.1002/(SICI)1521-3757(19991203)111:23<3646::AID-ANGE3646>3.0.CO;2-H>
5b. Angew. Chem., Int. Ed. 1999, 38, 3440.
< J., Davey R., Henck O.: https://doi.org/10.1002/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO;2-#>
6. Acc. Chem. Res. 1995, 28, 193.
< J. D., Bernstein J.: https://doi.org/10.1021/ar00052a005>
7. Solid State Sci. 2002, 4, 859.
< C., Jeß I., Havlas Z., Nagel N., Bolte M., Nick S.: https://doi.org/10.1016/S1293-2558(02)01324-9>
8. Adv. Drug Delivery Rev. 2001, 48, 91.
< K. R., Griesser U. J., Eckhardt C. J., Stowell J. G.: https://doi.org/10.1016/S0169-409X(01)00100-4>
9. Adv. Drug Delivery Rev. 2001, 48, 3.
< S. R., Brittain H. G., Grant D. J. W.: https://doi.org/10.1016/S0169-409X(01)00097-7>
10. Cryst. Res. Technol. 2001, 36, 1315.
< B., Nordhoff S., Ulrich J.: https://doi.org/10.1002/1521-4079(200112)36:12<1315::AID-CRAT1315>3.0.CO;2-R>
11. Cryst. Eng. Commun. 2005, 7, 439.
C. B., Samon D. J.:
12. Hatz H. J.: Glucocorticoide. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 2005.
13. Neeck G.: Neuroendocrine Immune Basis of the Rheumatic Diseases, Vol. II, Chap. 1, p. 28. Acad. Sciences, New York 2002.
14. Physiol. Rev. 1986, 66, 1121.
B. S., De Kloet E. R., Rostene W.:
15. Annu. Rev. Pharmacol. Toxicol. 1979, 19 179.
< J. E., Fauci A. S.: https://doi.org/10.1146/annurev.pa.19.040179.001143>
16. Schleimer R. P., Claman H. N., Oronsky A. L.: Anti-inflammatory Steroid Action: Basic and Clinical Aspects, p. 353. Academic Press, San Diego 1989.
17. Steroids 2002, 67, 529.
< F., Scheffold A.: https://doi.org/10.1016/S0039-128X(01)00171-4>
18. Pfeilschifter J., Steinhilber D.: Pharmazie in unserer Zeit (Glucocorticoide special edition) 2003, 4, 296.
19. Int. J. Pharm. 2006, 323, 101.
< V., Jeß I., Näther C.: https://doi.org/10.1016/j.ijpharm.2006.05.055>
20a. Angew. Chem. 2006, 118, 6529.
< C., Jeß I.: https://doi.org/10.1002/ange.200601468>
20b. Angew. Chem. Int. Ed. 2006, 45, 6381.
< C., Jeß I.: https://doi.org/10.1002/anie.200601468>
21. Solid State Sci. 2006, 8, 1373.
< V., Jeß I., Näther C.: https://doi.org/10.1016/j.solidstatesciences.2006.07.005>
22. Cryst. Growth Des. 2007, 7, 69.
< V., Jeß I., Näther C.: https://doi.org/10.1021/cg060434r>
23. Cryst. Growth Des. 2007, 8, 98.
< V., Jeß I., Sehnert J., Seyfarth L., Senker J., Näther C.: https://doi.org/10.1021/cg700866f>
24. J. Pharm. Sci. 2008, 97, 4516.
< V., Näther C., Jeß I.: https://doi.org/10.1002/jps.21334>
25. Cryst. Growth Des. 2009, 9, 772.
< V., Jeß I., Näther C.: https://doi.org/10.1021/cg8002838>
26. Int. J. Gynecol. Cancer 2006, 16, 494.
< M. J., De Bock H. G.: https://doi.org/10.1111/j.1525-1438.2006.00677.x>
27. Med. J. Aust. 2006, 185, 517.
C. H., Peake J. E.:
28. Steroids 2006, 72, 1.
< A. M., Klebe B., Germonpre P., De Backer W. A.: https://doi.org/10.1016/j.steroids.2006.10.007>
29. Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 407.
< F. H., Motherwell W. D. S.: https://doi.org/10.1107/S0108768102004895>
30. Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 380.
< H. H.: https://doi.org/10.1107/S0108768102003890>
31. Cambridge Structural Database V.5.29 (2010). Cambridge (UK) 2010.
32. J. Appl. Crystallogr. 2003, 36, 7.
< A. L.: https://doi.org/10.1107/S0021889802022112>
33. Acta Crystallogr., Sect A: Fundam. Crystallogr. 2008, 64, 112.
< G. M.: https://doi.org/10.1107/S0108767307043930>